课题基金 / 基金详情

项目摘要

项目成果

William Evan Johnson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recent efforts in large-scale data generation projects have attempted to produce genomic and epigenomic maps of multiple reference and cancer tissues (Epigenomic Roadmap, ENCODE, IHEC, TCGA). These orthogonal '-omic' profiles can be used to understand tissue-specific regulation in normal tissues, as well as identify regions of dysregulation that lead to disease. However, the data produced by different profiling approaches are typically heterogeneous and each specific platform suffers from different technical biases. Furthermore, current normalization and artifact correction methods are platform and data type specific, and may require both the training and test set for application, leading to data over-fitting, and renormalization or analysis modification if additional samples are later introduced. I this research, we will develop and demonstrate a comprehensive and coordinated framework for data standardization across tissue types and profiling platforms. We will develop algorithmic approaches for the uniform preprocessing of individual profiling samples that allow for seamless integration and interpretation across platforms, experiments, and techniques. We will use our standardized data to identify regions of coordinate and discordant epigenetic co-regulation across multiple tissue/cell types and across epigenomic profiling data platforms. Our particular focus will be across epithelial cell types. Finally, we will develop multi-'omic' drug efficacy biomarkers for epigenetic drugs across multiple tissue or cell types, followed by demonstration on patient samples from multiple public data resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbiome-based biomarkers and models of lung cancer development and treatment
Systems Biology Core
  • 批准号:
    10493266
  • 项目类别:
  • 资助金额:
    $35.78万
  • 财政年份:
    2021
  • 负责人:
    William Evan Johnson
  • 依托单位:
Microbiome-based biomarkers and models of lung cancer development and treatment
  • 批准号:
    10366665
  • 项目类别:
  • 资助金额:
    $23.14万
  • 财政年份:
    2021
  • 负责人:
    William Evan Johnson
  • 依托单位:
Systems Biology Core
海外基金